Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial
British Journal of Cancer, Published online: 25 March 2020; doi:10.1038/s41416-020-0785-yClinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Cesare Gridelli Tudor Ciuleanu Manuel Domine Aleksandra Szczesna Isabel Bover Manuel Cobo Nikolaos Kentepozidis Konstantinos Zarogoulidis Charalabos Kalofonos Andrzej Kazarnowisz Magdalena Korozan Ramon de las Penas Margarita Majem Antonio Chella Frank Gr Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Chemotherapy | Clinical Trials | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer | UK Health | Vaccines